Skip to main content
9409046853
e-ISSN: 2394-2967
British Journal of Medical and Health Research

British Journal of Medical and Health Research

📢 Latest Update: 🔔 Call for Papers 2026 | BJMHR Now Accepting Manuscripts for September 2026 Issue | Peer-Reviewed | Open Access | Fast Review in 5–7 Days | Submit Now

📢 Latest Update: 🔔 Call for Papers 2026 | BJMHR Now Accepting Manuscripts for September 2026 Issue | Peer-Reviewed | Open Access | Fast Review in 5–7 Days | Submit Now

Volume 13, Issue 10 - 2026 (October 2026 Issue 10)

Volume 13 Issue 10 Cover

Issue Details:

Volume 13 Issue 10
Published:Oct 2, 2026

Editorial: October 2026 Issue 10

Welcome to the 2026 issue of British Journal of Medical and Health Research. This issue showcases the remarkable breadth and depth of contemporary research across multiple disciplines. From cutting-edge applications of machine learning in climate science to the revolutionary potential of quantum computing in drug discovery, our featured articles demonstrate the power of interdisciplinary collaboration in addressing global challenges.

We are particularly excited to present research that bridges traditional academic boundaries, reflecting our journal's commitment to fostering innovation through cross-disciplinary dialogue. The integration of artificial intelligence with environmental science, the application of blockchain technology to supply chain management, and the convergence of urban planning with smart city technologies exemplify the transformative potential of collaborative research.

As we continue to navigate an era of rapid technological advancement and global challenges, the research presented in this issue offers both insights and solutions that will shape our future. We thank our authors, reviewers, and editorial board members for their continued dedication to advancing knowledge and promoting scientific excellence.

Dr J S Patel
Editor in Chief
British Journal of Medical and Health Research

Articles in This Issue

Showing 2 of 2 articles
Clinical trialsID: BJMHR10130001Pages 1-7Open AccessOpen Access

DIODE LASER MANAGEMENT OF BENIGN ORAL SOFT TISSUE MASSES: A CASE SERIES

Dr. Puja Sharma, 2) Dr. Peeyush Shivhare

Benign soft-tissue lesions of the oral cavity are frequently encountered in routine dental practice and may arise from the mucosa, gingiva, lips, buccal mucosa, tongue, palate, and other intraoral structures. These lesions encompass a diverse group of reactive, developmental, traumatic, inflammatory, and benign proliferative conditions, including fibroma, mucocele, papilloma, pyogenic granuloma, irritation fibroma, lipoma, epulis, gingival overgrowth, and other localized soft-tissue masses. Although conventional surgical excision with a scalpel remains the standard approach, the use of diode lasers has gained increasing interest because of their ability to provide precise soft-tissue cutting with simultaneous coagulation. The present case series evaluated the clinical application of diode laser in the management of four commonly encountered benign oral soft-tissue lesions: mucocele, traumatic fibroma, and pyogenic granuloma.

Diode laseroral soft tissue massfibromamucocelepyogenic granuloma
69,679 views
21,088 downloads

Contributors:

 Dr. Puja Sharma
,
 2) Dr. Peeyush Shivhare
Survey-based researchID: BJMHR10130002Pages 8-17Open AccessOpen Access

EVALUATION OF POTENTIALLY INAPPROPRIATE MEDICATIONS USE IN ELDERLY POPULATION AND THEIR IMPACT ON QUALITY OF LIFE USING BEERS CRITERIA

Aruna Palanisamy, Mrs. Merin Levy Philips, Durka Sri R, Bhoopalan Shanmugam

The growing geriatric population in India presents significant healthcare challenges, particularly regarding the safe and effective use of medications. This prospective, observational study was conducted over 10 months at a tertiary care hospital in Coimbatore to evaluate the use of potentially inappropriate medications (PIMs) among elderly patients using the 2023 Beers Criteria and to assess their impact on quality of life (QoL). Seventy-six patients aged 65 years and above were screened. Over 47% of prescriptions contained at least one PIM, with pantoprazole being the most frequently identified. The presence of multiple comorbidities and polypharmacy were common, leading to a high incidence of drug-drug interactions, including several with major severity. QoL was measured using the FANLTC-FACIT scale and revealed moderate scores in physical, social, and functional domains but notably lower scores in emotional well-being, particularly among female patients. The findings emphasize the need for clinical vigilance, routine prescription audits, and interprofessional collaboration to minimize PIMs and optimize pharmacotherapy in elderly care. Implementation of rational medication review and withdrawal strategies, along with adherence to updated geriatric prescribing guidelines among elderly patients, could substantially enhance QoL outcomes and reduce healthcare burdens.

Potentially Inappropriate Medications (PIMs)Beers CriteriaQuality of Life (QoL)Drug-Drug InteractionsElderlyFANLTC-FACIT
69,849 views
20,953 downloads

Contributors:

 Aruna Palanisamy
,
 Mrs. Merin Levy Philips
,
 Durka Sri R
,
 Bhoopalan Shanmugam
Whatsapp